Member Sign In

You are being directed to ZacksTrade, a division of Zacks & Company and licensed broker-dealer. ZacksTrade and Zacks.com are separate but affiliated companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.

If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.

Praxair Hikes Gas prices to Cover Increased Costs

You have chosen to follow this author. You will receive an email notification when this author publishes a new article. Click submit to continue.

You are alredy following the Author

The Author could not be added at this time, please try again later. If problem persists, please contact Zacks Customer support.

Please Login

Praxair Inc. (PX - Analyst Report), an industrial gas producer and supplier, announced price hikes for industrial, specialty and medical gases for its customers in the U.S., Canada, and Puerto Rico.

Prices of nitrogen, oxygen, hydrogen, helium and carbon dioxide have been revised up to 15%. Facility fees or monthly bulk product charges and cylinder rental rates have gone up by 10% while prices for hardgoods have also risen by 10%.

Praxair cited higher cost of production and distribution, feedstock sourcing and other operational factors as the primary reasons behind this revision. The revised rates will be applicable to bulk and packaged gas customers, effective Jul 15, 2014.

Earlier, in Apr 2014, price of argon was increased up to 20% while argon facility fees or monthly bulk product charges went up by 15%. These revised rates were applicable for Praxair’s bulk and packaged industrial, and specialty customers in the U.S. and Puerto Rico.

We believe Praxair’s profitability is highly dependent on costs of sales and expenses as any unwarranted increase in these will lower profitability and vice versa. In the past five years, the company’s cost of sales has increased by 34%.

Praxair is slated to report its second-quarter results on Jul 23, 2014 before the market opens. The Zacks Consensus Estimate is pegged at $1.59 for the quarter, and at $6.45 for 2014 and $7.20 for 2015. These estimates represent year-over-year growth of 6.4% for the second quarter, 8.8% for 2014 and 11.7% for 2015. Earnings in the next five years are anticipated to grow 11.7%.

Just Released: 5 Stocks Set to Double

Today, you are invited to download a free Special Report from Zacks Investment Research. It reveals five moves that could gain +100% and more in the next 12 months:

One company announced a cancer breakthrough that scored a 79% increase in progression-free survival in Phase III testing. Another is set to gain steam from a $3.45 billion acquisition. Still another has room for price increases that could send margins through the roof.

Top Zacks Features

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

Zacks Research is Reported On:

At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1986 it has nearly tripled the S&P 500 with an average gain of +26% per year. These returns cover a period from 1986-2011 and were examined and attested by Baker Tilly, an independent accounting firm.

Visit performance for information about the performance numbers displayed above.